Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma
NCT00002226 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2005-06-24
Summary
The purpose of this study is to see if it is safe and effective to give SU5416 to HIV-infected patients with AIDS-related Kaposi's sarcoma (KS). SU5416 may prevent the growth of KS tumors.
Conditions
- Sarcoma, Kaposi
- HIV Infections
Interventions
- DRUG
-
SU5416
Sponsors & Collaborators
-
SUGEN
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma
NCT05411237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
NCT00000681 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000996 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma
NCT00000660 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma
NCT00002212 ·Status: COMPLETED ·Phase: PHASE2
-
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
NCT00005862 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00000987 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
NCT00002445 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma
NCT00002314 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
NCT00023725 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
EMD 121974 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00006222 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
NCT00000954 ·Status: COMPLETED ·Phase: PHASE1
-
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00450320 ·Status: COMPLETED ·Phase: PHASE1
-
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)
NCT03157167 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma
NCT02029430 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Selumetinib in Patients With Kaposi's Sarcoma
NCT01752569 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma
NCT00002259 ·Status: COMPLETED ·Phase: PHASE2
-
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
NCT00686842 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection
NCT03601806 ·Status: COMPLETED ·Phase: PHASE2
-
Thalidomide in Treating Patients With HIV-Associated Kaposi's Sarcoma
NCT00019123 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma
NCT03316274 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
NCT00001059 ·Status: COMPLETED ·Phase: PHASE2
-
BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00024024 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
NCT04893018 ·Status: TERMINATED ·Phase: PHASE1
-
Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma
NCT00002985 ·Status: COMPLETED ·Phase: PHASE3